EP0575927B1 - Verfahren zum Äschern von Häuten und Fellen - Google Patents
Verfahren zum Äschern von Häuten und Fellen Download PDFInfo
- Publication number
- EP0575927B1 EP0575927B1 EP93109846A EP93109846A EP0575927B1 EP 0575927 B1 EP0575927 B1 EP 0575927B1 EP 93109846 A EP93109846 A EP 93109846A EP 93109846 A EP93109846 A EP 93109846A EP 0575927 B1 EP0575927 B1 EP 0575927B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- liming
- alkaline
- elastase
- skins
- proteases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 35
- 108010067372 Pancreatic elastase Proteins 0.000 claims abstract description 27
- 102000016387 Pancreatic elastase Human genes 0.000 claims abstract description 27
- 230000000694 effects Effects 0.000 claims abstract description 25
- RYYXDZDBXNUPOG-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride Chemical compound Cl.Cl.C1C(N)CCC2=C1SC(N)=N2 RYYXDZDBXNUPOG-UHFFFAOYSA-N 0.000 claims abstract description 21
- 108091005658 Basic proteases Proteins 0.000 claims abstract description 19
- 108091005804 Peptidases Proteins 0.000 claims abstract description 19
- 102000035195 Peptidases Human genes 0.000 claims abstract description 17
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 claims abstract description 4
- 239000004365 Protease Substances 0.000 claims description 14
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 claims description 11
- 241000193375 Bacillus alcalophilus Species 0.000 claims description 9
- 230000001580 bacterial effect Effects 0.000 claims description 6
- 108010083498 alkaline elastase Proteins 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 26
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- 210000003491 skin Anatomy 0.000 description 21
- 102000004190 Enzymes Human genes 0.000 description 17
- 108090000790 Enzymes Proteins 0.000 description 17
- 229940088598 enzyme Drugs 0.000 description 17
- NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 14
- 239000004471 Glycine Substances 0.000 description 13
- 210000004209 hair Anatomy 0.000 description 10
- 102000016942 Elastin Human genes 0.000 description 8
- 108010014258 Elastin Proteins 0.000 description 8
- 229920002549 elastin Polymers 0.000 description 8
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 7
- 239000000920 calcium hydroxide Substances 0.000 description 7
- 235000011116 calcium hydroxide Nutrition 0.000 description 7
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 7
- 238000011088 calibration curve Methods 0.000 description 6
- 239000010985 leather Substances 0.000 description 6
- 230000002797 proteolythic effect Effects 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 230000008033 biological extinction Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000035617 depilation Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- KDZCMNKCNXVTIK-UHFFFAOYSA-N sulfonylmethanediamine Chemical compound NC(N)=S(=O)=O KDZCMNKCNXVTIK-UHFFFAOYSA-N 0.000 description 4
- 239000002351 wastewater Substances 0.000 description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 3
- 235000011941 Tilia x europaea Nutrition 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 230000003165 hydrotropic effect Effects 0.000 description 3
- 239000004571 lime Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000019419 proteases Nutrition 0.000 description 3
- 241000228212 Aspergillus Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 229940079919 digestives enzyme preparation Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229910052945 inorganic sulfide Inorganic materials 0.000 description 2
- 238000005554 pickling Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- HYHCSLBZRBJJCH-UHFFFAOYSA-M sodium hydrosulfide Chemical compound [Na+].[SH-] HYHCSLBZRBJJCH-UHFFFAOYSA-M 0.000 description 2
- 229910052979 sodium sulfide Inorganic materials 0.000 description 2
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 2
- -1 sulfide ions Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- TYCDGIBDMITBCH-UHFFFAOYSA-N 2-(dimethylamino)naphthalene-1-sulfonic acid Chemical compound C1=CC=CC2=C(S(O)(=O)=O)C(N(C)C)=CC=C21 TYCDGIBDMITBCH-UHFFFAOYSA-N 0.000 description 1
- NYYSPVRERVXMLJ-UHFFFAOYSA-N 4,4-difluorocyclohexan-1-one Chemical compound FC1(F)CCC(=O)CC1 NYYSPVRERVXMLJ-UHFFFAOYSA-N 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 241000203233 Aspergillus versicolor Species 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 108010082503 alkaline elastase YaB Proteins 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000003246 elastolytic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000005337 ground glass Substances 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000510 mucolytic effect Effects 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- OIPPWFOQEKKFEE-UHFFFAOYSA-N orcinol Chemical compound CC1=CC(O)=CC(O)=C1 OIPPWFOQEKKFEE-UHFFFAOYSA-N 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000004763 sulfides Chemical class 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C14—SKINS; HIDES; PELTS; LEATHER
- C14C—CHEMICAL TREATMENT OF HIDES, SKINS OR LEATHER, e.g. TANNING, IMPREGNATING, FINISHING; APPARATUS THEREFOR; COMPOSITIONS FOR TANNING
- C14C1/00—Chemical treatment prior to tanning
- C14C1/06—Facilitating unhairing, e.g. by painting, by liming
-
- C—CHEMISTRY; METALLURGY
- C14—SKINS; HIDES; PELTS; LEATHER
- C14C—CHEMICAL TREATMENT OF HIDES, SKINS OR LEATHER, e.g. TANNING, IMPREGNATING, FINISHING; APPARATUS THEREFOR; COMPOSITIONS FOR TANNING
- C14C1/00—Chemical treatment prior to tanning
- C14C1/06—Facilitating unhairing, e.g. by painting, by liming
- C14C1/065—Enzymatic unhairing
Definitions
- the invention relates to a method for liming skins and furs, the aqueous liming liquor containing alkaline proteases simultaneously with thiourea dioxide.
- THDO thiourea dioxide
- formamidine sulfinic acid was proposed as a sulfide substitute (AT-PS 381 952, EP 197 918).
- This compound has a very high reduction potential compared to cysteine, so that in doses of 0.1-1% by weight, perfect depilation can be achieved together with calcium oxide or calcium carbonate.
- the compound is largely odorless and the degree of preservation of the hair is significantly better than that of a pure sulphide ash.
- the compound has a low toxicity to wastewater, since it is readily biodegradable.
- the present invention thus relates to a process for the liming of hides and skins, the aqueous liming liquors having a pH in the range 10-14, preferably 12-14, containing thiourea dioxide and alkaline proteases AP with elastase activity.
- the liming liquors preferably contain 0.3 to 2% by weight, in particular 0.5 to 1% by weight, of thiourea dioxide together with an effective amount of one or more alkaline proteases AP.
- the liming process in the sense of the present invention summarizes the hair loosening, the actual liming, the skin disruption and, if necessary, the post-liming.
- THDO and alkaline proteases according to the invention is therefore excellently suitable for sulfide-free liming and / or post-liming as well as for low-sulfide liming / post-liming.
- alkaline proteases AP with elastase activity The alkaline proteases AP with elastase activity
- Elastase preparations even in crystallized form, must be regarded as inconsistent from the start; Even the purest preparations still contain a part of proteolytic, non-elastolytic activity. In structure and specific activity, the elastases seem to resemble trypsin and chymotrypsin. The quantitative determinations are based on the (both proteolytic and mucolytic) degradation of the elastin. The main method of determination is the degradation of elastin, which is loaded with dyes such as orcin (or Congo red, dimethylaminonaphthalene sulfonic acid) or fluorescein.
- dyes such as orcin (or Congo red, dimethylaminonaphthalene sulfonic acid) or fluorescein.
- alkaline proteases AP to be used according to the invention with elastase activity are characterized by an optimum activity in the alkaline pH range, generally in the range pH 12 ⁇ 2.
- microorganisms in particular of the bacterial type, especially the bacilli, are currently the preferred starting materials.
- Other examples include Flavobacterium elastolyticum, Chlortridium histolyticum, Staph. epidermis.
- alkaline proteases In the case of preparations of alkaline proteases from Bacillus types, portions of 30-60% by weight of alkaline protease, 0.002-2% by weight of elastase in addition to neutral proteinase and collagenase (see USSR-PS 802 909, Chem. Abstr 94 , 148 340x). Alkaline elastases have recently also been produced as products of genetic manipulation, for example by cloning the alkaline elastase gene from alkalophilic Bacillus and expression in Bacillus subtilis (cf. JP-OS 90 76 586, Chem. Abstr. 115 , 249 561c; Y.Ch. Tsai et al. Biochim.
- EUgly elastase units The units of elastase activity determined in the manner specified there are hereinafter referred to as EUgly elastase units.
- the definition is: One elastase unit (EUgly) corresponds to the extinction of a ⁇ Mol glycine by trinitrobenzenesulfonic acid determination; Analysis conditions: substrate is elastin, in buffer pH 8 and at 37 degrees C whereby the increase in extinction per minute is evaluated.
- the activities of the active enzymes in the enzyme preparations AP are preferably in a certain ratio in the process according to the invention.
- the protease activity of the alkaline protease [in Löhlein-Volhard units (LVE)] divided by a thousand times one Factor F gives the number of elastase activity in the units EUgly chosen for the purposes of the present invention (cf. experimental part). According to the invention, the factor F is between 0.6 and 20, preferably 1 to 5.
- alkaline proteases present in the enzyme preparations AP that can be used according to the invention are characterized in the usual way. (See Kirk-Othmer 3rd. Ed. Vol. 9, pp. 199-202, J. Wiley 1980; Ullmann's Encyclopedia of Industrial Chemistry Vol. A9, pp. 409-414, VCH 1987; L. Keay in "Process Biochemistry 17-21 (1971) These proteases, which mostly belong to the serine type, usually develop their optimum activity in a pH range of about 8-13.
- Bacterial proteases in particular from Bacillus strains, are particularly mentioned, advantageously those which contain the elastase Bring activities from their origin, however, alkaline proteases of different origins can also be combined with one another, the elastase activity having to be introduced by appropriate addition.
- alkaline proteases are, above all, those obtained from Bacillus strains, especially B.subtilis, but also B.formus, B.licheniformis, B.alcalophilus, B.polymixa, B.mesentericus, and also from Streptomyces strains such as S.alcalophilus called.
- the cheapest working temperature with alkaline bacterial proteases is generally 40 - 60 degrees C, with fungal proteases rather at 20 - 40 degrees C.
- Alkaline fungal proteases include those from Aspergillus strains such as A.oryzae, from Penicillinum strains such as P.cyanofulvum or Paecilumyces persicinus.
- the activity of the alkaline fungal proteases is predominantly in the pH range 8.0 - 11.0.
- the proteolytic activity of the alkaline proteases is customarily determined by the Anson hemoglobin method (cf. ML Anson J. Gen. Physiol. 22 , 79 (1939) or by the Löhlein-Volhard method (modified according to TEGEWA, cf. Leder, 22 , 121 - 126 1971).
- One Löhlein-Volhard unit corresponds to the amount of enzyme that causes an increase in hydrolysis product in 20 ml casein filtrate, corresponding to an equivalent of 5.75 ⁇ 10 -3 ml 0.1 N NaOH.
- the protease activity to be used is generally between 1,000 and 60,000 LVU per kg skin, preferably between 2,000 and 14,000 LVU per kg skin.
- the process according to the invention usually comes with amounts of proteases between 0.05 to 0.8% by weight, preferably about 0.1 to 0.3% by weight, as a rule of thumb when using an alkaline bacterial protease (Bacillus alcalophilus) ) with 4,000 LVE based on the weight of the hides and skins used.
- 0.3-2% by weight, preferably 0.5-1% by weight, of thiourea dioxide are used together with the proteolytic enzymes AP.
- the fleet length is usually 100 to 120 wt .-% based on the weight of the hides and skins used.
- the pH range of the liquor is advantageously adjusted using hydrated lime, but sodium hydroxide solution and / or soda can also be used proportionally.
- agents known per se such as, for example, organic amines, for example diethanolamine and / or hydrotropic substances such as, for example, urea, can also be used.
- a dirt switch and a main switch are carried out for the pretreatment (US Pat. No. 4,344,762).
- the main switch as is customary in the business, is carried out using suitable proteases and / or surfactants at a pH of 9-10 over a period of 4-6 hours.
- the main switch fleet is typically drained and a new bath is continued.
- the enzymatic reaction is carried out in the temperature range 20-28 degrees C., preferably at 26 degrees C.
- the liquor containing the enzymes and the thiourea dioxide which is adjusted to an alkaline pH, especially in the range 10-13, is left in a conventional reaction vessel, for example a mixer, tanning drum, etc., with agitation, for example, for a sufficient period of time, as a rule of thumb there are approximately 90 Called minutes, act on the hides and skins until they are largely hair-free. Then it can be post-alkalized with a little alkali, for example 0.2% by weight of a 50% sodium hydroxide solution, preferably with agitation for about 30 minutes.
- a conventional reaction vessel for example a mixer, tanning drum, etc.
- the process according to the invention permits the production of remarkably soft leather, it being particularly emphasized that despite the use of degrading enzymes there is generally a completely intact scar pattern. Overall, the result can be regarded as very surprising, since the nubucking to be expected when using the enzyme in the liming occurs less than the expected loose grain in the flames.
- the required amount can be used Significantly reduce thiourea dioxide.
- the combination of thiourea dioxide and alkaline protease in the liming thus enables an ecologically extremely favorable liming process, which combines high leather quality with sufficient application safety.
- the ecological advantage lies primarily in the good hair preservation and thus the lower COD pollution in the wastewater as well as in the avoidance of any use of sulfide.
- Dirt diverter main diverter is normally used by using tensides at pH 9-10 for 4-6 hours.
- the main switch fleets are drained and all examples continue to work in a new bath.
- 1 unit of elastase corresponds to the amount of enzyme that causes staining with TNBS equivalent to 1 ⁇ mol of glycine per minute in an elastin suspension under the specified standard conditions.
- 250 mg of elastin are weighed into a 50 ml narrow-neck Erlenmeyer flask with a ground glass stopper and mixed with 10 ml of 0.1 m borate buffer.
- the flask is preheated in the shaking thermostat for 10 min. After adding 1 ml of enzyme solution, the mixture is mixed well and the flask is returned to the shaking thermostat. Temperature: 37 degrees C.
- the reaction is stopped by filtering the reaction mixture through a pleated filter after exactly 2 hours.
- the fragments are immediately stained using the TNBS method .
- TNBS Response:
- test tube 100 ⁇ l of the sample are added to 8 ml of TNBS reagent and the test tube is left for 25 min. stand in a water bath at 50 degrees C. After exactly 25 min. the test tube is 5 min. placed in ice water and immediately afterwards the absorbance measured at 420 nm.
- the enzyme solution is only added after the second hour of the reaction time.
- the further treatment is the same as for the main value, i.e. begins with the stopping.
- the staining of glycine with TNBS is measured and in addition ⁇ mol of glycine against O.D. applied.
- the blank value (O.D. of TNBS reagent + 10 l distilled water) was previously subtracted from all glycine values.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Treatment And Processing Of Natural Fur Or Leather (AREA)
- Cosmetics (AREA)
- Glass Compositions (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
- Gloves (AREA)
- Laminated Bodies (AREA)
- Coloring (AREA)
- Adornments (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4220838 | 1992-06-25 | ||
DE4220838A DE4220838A1 (de) | 1992-06-25 | 1992-06-25 | Verfahren zum Äschern von Häuten und Fellen |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0575927A2 EP0575927A2 (de) | 1993-12-29 |
EP0575927A3 EP0575927A3 (enrdf_load_stackoverflow) | 1994-02-09 |
EP0575927B1 true EP0575927B1 (de) | 1996-08-28 |
Family
ID=6461801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP93109846A Expired - Lifetime EP0575927B1 (de) | 1992-06-25 | 1993-06-21 | Verfahren zum Äschern von Häuten und Fellen |
Country Status (10)
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4332785A1 (de) * | 1993-09-27 | 1995-03-30 | Roehm Gmbh | Verbessertes enzymunterstütztes Äscherverfahren |
US6340458B1 (en) * | 1999-11-19 | 2002-01-22 | Reva Amir | Use of enzymes for skin expansion |
JP2001164300A (ja) * | 1999-12-06 | 2001-06-19 | Daiwa Kasei Kk | 皮革鞣製における酵素脱毛剤及び酵素脱毛法 |
US20030061666A1 (en) * | 2001-05-01 | 2003-04-03 | Blc Leather Technology Centre Limited Leather Trade House | Leather processing |
RU2178810C1 (ru) * | 2001-05-25 | 2002-01-27 | Федеральное государственное унитарное предприятие Центральный научно-исследовательский институт кожевенно-обувной промышленности | Способ обработки кожевенного сырья |
US6777219B2 (en) * | 2002-03-13 | 2004-08-17 | Council Of Scientific And Industrial Research | Process for the preparation of alkaline protease |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1011668B (it) * | 1973-04-28 | 1977-02-10 | Roehm Gmbh | Procedimento di purga delle pelli |
DE2917376C2 (de) * | 1979-04-28 | 1987-03-26 | Röhm GmbH, 6100 Darmstadt | Enzymatisches Verfahren zur Haargewinnung und zum gleichzeitigen Hautaufschluß |
AT381952B (de) * | 1985-04-03 | 1986-12-29 | Oesterr Chem Werke | Verfahren zum aeschern von haeuten und fellen |
AT388387B (de) * | 1987-09-02 | 1989-06-12 | Oesterr Chem Werke | Verfahren zum nachaeschern von bloesen und spalten |
DE3802640A1 (de) * | 1988-01-29 | 1989-08-03 | Roehm Gmbh | Haarerhaltendes aescherverfahren |
DE3922748B4 (de) * | 1989-07-11 | 2006-01-05 | Röhm GmbH & Co. KG | Enzymatisches Weichverfahren |
-
1992
- 1992-06-25 DE DE4220838A patent/DE4220838A1/de not_active Withdrawn
-
1993
- 1993-06-21 ES ES93109846T patent/ES2091523T3/es not_active Expired - Lifetime
- 1993-06-21 DE DE59303551T patent/DE59303551D1/de not_active Expired - Lifetime
- 1993-06-21 DK DK93109846.1T patent/DK0575927T3/da active
- 1993-06-21 EP EP93109846A patent/EP0575927B1/de not_active Expired - Lifetime
- 1993-06-21 AT AT93109846T patent/ATE141959T1/de not_active IP Right Cessation
- 1993-06-24 BR BR9302644A patent/BR9302644A/pt not_active IP Right Cessation
- 1993-06-24 JP JP15340893A patent/JP3211914B2/ja not_active Expired - Fee Related
- 1993-06-24 MX MX9303809A patent/MX9303809A/es not_active IP Right Cessation
- 1993-06-25 KR KR1019930011654A patent/KR100256152B1/ko not_active Expired - Fee Related
-
1995
- 1995-09-26 US US08/533,674 patent/US5508195A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP3211914B2 (ja) | 2001-09-25 |
US5508195A (en) | 1996-04-16 |
EP0575927A3 (enrdf_load_stackoverflow) | 1994-02-09 |
BR9302644A (pt) | 1994-01-11 |
EP0575927A2 (de) | 1993-12-29 |
KR100256152B1 (en) | 2000-06-01 |
ATE141959T1 (de) | 1996-09-15 |
JPH0657300A (ja) | 1994-03-01 |
ES2091523T3 (es) | 1996-11-01 |
DE4220838A1 (de) | 1994-01-05 |
DE59303551D1 (de) | 1996-10-02 |
DK0575927T3 (da) | 1996-09-30 |
MX9303809A (es) | 1994-01-31 |
KR940005808A (ko) | 1994-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3704465C2 (de) | Flüssig-Formulierungen von Enzymen | |
EP0753058B1 (de) | Hochalkalische protease und deren verwendung | |
EP0326059B1 (de) | Haarerhaltendes Äscherverfahren | |
DE3429047C2 (enrdf_load_stackoverflow) | ||
DE2404789B2 (de) | Verfahren zur Herstellung gerbfertiger Blößen aus tierischen Häuten und Fellen | |
DE2917376C2 (de) | Enzymatisches Verfahren zur Haargewinnung und zum gleichzeitigen Hautaufschluß | |
EP0575927B1 (de) | Verfahren zum Äschern von Häuten und Fellen | |
EP0505920B1 (de) | Enzymatisch unterstütztes Äscherverfahren | |
DE3312840A1 (de) | Verfahren zur nassentfettung von hautmaterial | |
DE69202522T2 (de) | Verfahren zur Enthaarung von Tierhäuten. | |
DE2856320C2 (enrdf_load_stackoverflow) | ||
EP0728844B1 (de) | Mehrfunktionelle Lederbearbeitungsmittel | |
EP0216271B1 (de) | Verwendung von Phosphonsäurederivaten als Lederhilfsmittel | |
DE2836824C2 (de) | Verfahren zur enzymatischen Pelzweiche | |
EP0464531B1 (de) | Enzymatische Beizpräparate | |
DE102007013950A1 (de) | Eine neue Protease für industrielle Anwendungen | |
DE4035839A1 (de) | Protease als wirkenzym enthaltende, tensidfreie feste enzympraeparate | |
AT400957B (de) | Verfahren zum entfleischen von häuten und fellen bei der lederherstellung | |
DE4332785A1 (de) | Verbessertes enzymunterstütztes Äscherverfahren | |
DE767061C (de) | Verfahren zum Beizen von geaescherten Hautbloessen | |
DE10106541B4 (de) | Enzympräparat und dessen Verwendung in der Gerberei | |
DE977414C (de) | Verfahren zum AEschern von Fellen und Haeuten mit proteolytischen Enzymen | |
DE4119889A1 (de) | Verfahren zur weiche, zur waesche, zum aescher und zur beize | |
DE2307603C3 (enrdf_load_stackoverflow) | ||
DE3513253A1 (de) | Verfahren zur raschen enzymatischen enthaarung von haeuten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB IT LI NL SE |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB IT LI NL SE |
|
17P | Request for examination filed |
Effective date: 19940311 |
|
17Q | First examination report despatched |
Effective date: 19950905 |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
ITF | It: translation for a ep patent filed | ||
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB IT LI NL SE |
|
REF | Corresponds to: |
Ref document number: 141959 Country of ref document: AT Date of ref document: 19960915 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
REF | Corresponds to: |
Ref document number: 59303551 Country of ref document: DE Date of ref document: 19961002 |
|
ET | Fr: translation filed | ||
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2091523 Country of ref document: ES Kind code of ref document: T3 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: BOVARD AG PATENTANWAELTE |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 19961129 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20010612 Year of fee payment: 9 |
|
NLT1 | Nl: modifications of names registered in virtue of documents presented to the patent office pursuant to art. 16 a, paragraph 1 |
Owner name: ROEHM GMBH & CO. KG |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20020630 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20020630 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20050516 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20050531 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20050601 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20050614 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20050624 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20050629 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20050819 Year of fee payment: 13 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20060228 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20060228 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: RN |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20060621 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20060621 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20060622 Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20060622 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20060630 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20060630 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: FC |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070101 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP |
|
EUG | Se: european patent has lapsed | ||
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20060621 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 20070101 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20060622 |
|
BERE | Be: lapsed |
Owner name: *ROHM G.M.B.H. Effective date: 20060630 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20070509 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20070627 Year of fee payment: 15 |
|
PGRI | Patent reinstated in contracting state [announced from national office to epo] |
Ref country code: FR Effective date: 20060531 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20090228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080621 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080630 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20110905 Year of fee payment: 19 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 59303551 Country of ref document: DE Effective date: 20130101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130101 |